By establishing a breast cancer disease network and enriching the key nodes and pathways for the regulation of cinnamon active ingredients, we found that antioxidant activity and the PI3K-Akt and NF-κB signaling pathways play important roles in the pharmacological effects of cinnamon. Here, AKT1 is linked to breast carcinoma.